Ticagrelor

Product Specifications

CAS Number

274693-27-5

Target

Cytochromes P450, P2Y Receptor

Related Pathways

Metabolism, Neuroscience, GPCR/G Protein

Purity

>99.99%

Bioactivity

Ticagrelor (AR-C 126532XX), produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20, 2011. Its trade names are Brilinta (US), Brilique (EU) and Possia (EU) .

Smiles

CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1

Molecular Formula

C23H28F2N6O4S

Molecular Weight

522.57

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

MBS4381799-01 0.02 mg (With BSA & Azide at 0.2mg/mL)

CD35/CR1 (Follicular Dendritic Cell Marker) Recombinant Rabbit Monoclonal Antibody [Clone CR1/7016R]

View Details

MBS4381799-02 0.1 mg (With BSA & Azide at 0.2mg/mL)

CD35/CR1 (Follicular Dendritic Cell Marker) Recombinant Rabbit Monoclonal Antibody [Clone CR1/7016R]

View Details

MBS4381799-03 0.1 mg (Without BSA & Azide at 1mg/mL)

CD35/CR1 (Follicular Dendritic Cell Marker) Recombinant Rabbit Monoclonal Antibody [Clone CR1/7016R]

View Details

MBS4381799-04 5x 0.1 mg (With BSA & Azide at 0.2mg/mL)

CD35/CR1 (Follicular Dendritic Cell Marker) Recombinant Rabbit Monoclonal Antibody [Clone CR1/7016R]

View Details

MBS4381799-05 5x 0.1 mg (Without BSA & Azide at 1mg/mL)

CD35/CR1 (Follicular Dendritic Cell Marker) Recombinant Rabbit Monoclonal Antibody [Clone CR1/7016R]

View Details

ELK9737-01 48 Tests

Human CD3 (Cluster of Differentiation 3) ELISA Kit

View Details